[Morphological studies of the effect of beta-blocker in drug induced ocular hypertension. 2. Ocular hypertension following the topical application of prostaglandin E2].
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002924:Ciliary Body / Q000648:ultrastructure; D015232:Dinoprostone; D009798:Ocular Hypertension / Q000139:chemically induced* / Q000473:pathology; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology*; D011817:Rabbits
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011412:Propanolamines; D011458:Prostaglandins E; C006034:befunolol; D015232:Dinoprostone